Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000903423-16-001320

10% owner bought 66,500 shares at $14.00 ($931,000)

  • 10% owner acquired 3,154,127 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GLAXOSMITHKLINE PLC 10% owner 2016-10-24 Conversion +2,942,560 2,942,560 I
GLAXOSMITHKLINE PLC 10% owner 2016-10-24 Conversion +211,567 3,154,127 I
GLAXOSMITHKLINE PLC 10% owner 2016-10-24 Purchase +66,500 $14.00 $931,000 3,220,627 I
Derivatives
GLAXOSMITHKLINE PLC 10% owner 2016-10-24 Conversion · Series A-3 Preferred Shares −2,942,560 0 I
GLAXOSMITHKLINE PLC 10% owner 2016-10-24 Conversion · Series B Preferred Shares −211,567 0 I
Open-market purchases · 66,500 sh · avg $14.00 · $931,000
Loading xslF345X03/glaxo-crispr.xml…